| NCT ID | NCT07317271 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins University |
| Condition | Burn |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2026-02-27 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2026-02-27 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn whether progressive muscle relaxation (PMR), delivered either alone or enhanced with virtual reality (VR), can help treat chronic symptom, such as pain, itch, anxiety, sleep disturbances, and fatigue, in adult burn survivors. The main questions it aims to answer are: * Does VR-enhanced PMR (VR-PMR) reduce chronic pain, anxiety, itch, sleep disturbances, and fatigue more effectively than standard PMR? * Is VR-PMR a feasible and acceptable self-administered home-based intervention for burn survivors? Researchers will compare two self-administered intervention conditions, VR-enhanced PMR and standard PMR, using a randomized to sequence crossover design to see if VR technology enhances the therapeutic effects of PMR on chronic symptom management in burn survivors. Participants will: * Complete home-based sessions of VR-enhanced PMR * Complete home-based sessions of standard PMR * Report symptoms such as pain, itch, anxiety, sleep disturbances, and fatigue throughout the study * Use VR equipment provided for the intervention period (during the VR-PMR arm)
Eligibility Criteria
Inclusion criteria are: * ≥18 years old; * sustained a burn injury in the last 6 months or longer; * Score high on at least one of the following: Insomnia severity index (ISI) score of ≥8, Brief Pain Inventory Short Form (BPI-SF) Pain severity score of ≥3, or PROMIS Itch Severity of ≥55; * own a smartphone or computer with reliable internet connection for online visits and survey completion; * able to comfortably wear goggles or headsets on face as determined by self-report. Exclusion criteria: * Cognitive impairment (Mini Mental Status Exam (MMSE) \< 25); * history of motion sickness, photosensitivity, photoinduced seizures, and claustrophobia as determined by self-report; * uncorrected visual or hearing impairments as determined by self-report; * non-English speaker.
Contact & Investigator
Sheera Lerman Zohar, PhD
PRINCIPAL INVESTIGATOR
Johns Hopkins University
Frequently Asked Questions
Who can join the NCT07317271 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Burn. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07317271 currently recruiting?
Yes, NCT07317271 is actively recruiting participants. Contact the research team at lnakad1@jhmi.edu for enrollment information.
Where is the NCT07317271 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT07317271 clinical trial?
NCT07317271 is sponsored by Johns Hopkins University. The principal investigator is Sheera Lerman Zohar, PhD at Johns Hopkins University. The trial plans to enroll 34 participants.